Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-476 Phase III Open Label Exploratory Comparative Study in Acute Exacerbations of Asthma
2014-004749-28Phase 3
- Sponsor
- Banyu Pharmaceutical
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of montelukast in asthma (3 arms), sponsored by Banyu Pharmaceutical. Primary endpoint: Time-weighted average change in FEV1 (0-60 min).
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-004749-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004749-28.